CHRS Reports 124.6M Votes for Proposals 1-3,5; 91.8M Votes for Proposal 4; $0 Broker Non‑Votes on Routine Items
Coherus Oncology, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.57
+1.2% in 1h after detection
Post-detection moves
1h
+1.2%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS